| |
| |
|
| Insider
Information: |
Czirr James C |
| Relationship: |
10% Owner |
| City: |
Sandpoint |
| State: |
ID |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
6,168,940 |
|
|
Indirect Shares
|
5,922,207 |
|
|
| Direct
Value |
$13,571,668 |
|
|
|
Indirect Value
|
$13,028,855 |
|
|
| Total
Shares |
12,091,147 |
|
|
| Total
Value |
$26,600,523 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -98.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
10% Owner |
2022-07-22 |
6,168,940 |
2024-04-23 |
5,922,207 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-06-14 |
4 |
AS |
$7.99 |
$632,133 |
I/I |
(76,385) |
2,725,261 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-06-15 |
4 |
AS |
$8.47 |
$131,073 |
I/I |
(15,475) |
2,709,786 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-06-18 |
4 |
AS |
$9.06 |
$543,600 |
I/I |
(60,000) |
2,649,786 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • – |
2013-10-07 |
4 |
S |
$11.79 |
$1,179,160 |
I/I |
(100,000) |
8,969,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • – |
2013-10-08 |
4 |
S |
$12.36 |
$148,270 |
I/I |
(12,000) |
8,957,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • – |
2014-01-13 |
4 |
S |
$14.00 |
$812,203 |
I/I |
(58,000) |
9,357,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • – |
2014-01-10 |
4 |
S |
$16.00 |
$672,118 |
I/I |
(42,000) |
9,415,422 |
0 |
- |
|
107 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
